Search

1. The "deemed to be a license" provision of the BPCI Act: questions and answers

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, March 2020

Subject(s):

Biological Products
Drug Approval
Licensure
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. "I swear by Apollo physician--": Greek medicine from the gods to Galen

Publication:

[Bethesda, Md. : Medical Arts and Photography Branch, National Institutes of Health, 2002]

Subject(s):

History of Medicine
Exhibitions as Topic
History, Ancient
Greece, Ancient
Galen.

3. ["Tree of Hippocrates" plaque]

Author(s):

Greenberg, Stephen J., photographer

Publication:

Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, [2017]

Subject(s):

Trees
National Library of Medicine (U.S.)

4. The 'New Federalism' and Public Health: Keynote Address to the 18th Annual Conference of the New England Public Health Association, Wychmere Harbor, Cape Cod, Massachusetts [Reminiscence]

Publication:

Produced: 2003

Archival Collection:

The C. Everett Koop Papers (Profiles in Science)

5. The 2018 long-term budget outlook

Publication:

Washington, D.C. : Congressional Budget Office, June 2018

Subject(s):

Budgets -- trends
Federal Government
United States

6. The 2019 long-term budget outlook

Publication:

[Washington, DC] : Congressional Budget Office, June 2019

Subject(s):

Budgets -- trends
Gross Domestic Product -- trends
United States

7. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, December 16, 2019

Subject(s):

Device Approval -- standards
Equipment and Supplies -- standards
Manufactured Materials -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

8. 340B Drug Discount Program: oversight of the Intersection with the Medicaid Drug Rebate Program needs improvement : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, January 2020

Subject(s):

Drug Costs -- legislation & jurisprudence
Government Regulation
Medicaid -- economics
United States
United States. Department of Health and Human Services

9. 510(k) third party review program: guidance for industry, Food and Drug Administration staff, and third party review organizations

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, March 12, 2020

Subject(s):

Device Approval
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

10. ACF cannot ensure that all child victims of abuse and neglect have court representation

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021

Subject(s):

Child Abuse -- legislation & jurisprudence
Child Protective Services -- standards
Government Regulation
Legal Services -- organization & administration
United States
United States. Department of Health and Human Services

11. ACF should improve oversight of head start to better protect children’s safety

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

Child Health
Government Regulation
Early Intervention, Educational
United States
United States. Administration for Children and Families

12. ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019

Subject(s):

Accountable Care Organizations -- economics
Cost Savings
Medicare -- economics
Quality of Health Care
Value-Based Purchasing
United States

13. ANDA submissions--amendments to abbreviated new drug applications under GDUFA

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2018

Subject(s):

Drugs, Generic -- standards
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

14. ANDA submissions: amendments and requests for final approval to tentatively approved ANDAs

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2020

Subject(s):

Drug Approval
Drug Industry
Drugs, Generic
Therapeutic Equivalency
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

15. ANDAs for certain highly purified synthetic peptide drug products that refer to listed drugs of rDNA origin

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2021

Subject(s):

Chemistry Techniques, Synthetic
DNA, Ribosomal
Drug Approval
Drugs, Generic
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

16. Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate

Publication:

Washington, DC : United States Government Accountability Office, December 2022

Subject(s):

Elder Abuse -- legislation & jurisprudence
Government Regulation
Hospice Care -- legislation & jurisprudence
Legislation, Medical
Mandatory Reporting
Medicaid -- organization & administration
Medicare -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)

17. Accelerating adoption of assistive technology to reduce physical strain among family caregivers of the chronically disabled elderly living at home

Author(s):

Lewin Group, author.

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Assistant Secretary for Planning and Evaluation, Office of Disability, Aging and Long-Term Care Policy, January 14, 2012

Subject(s):

Caregivers
Self-Help Devices -- statistics & numerical data
Aged
Persons with Disabilities
Respite Care
United States
National Family Caregiver Support Program (U.S.)

18. Acceptance and filing reviews for premarket approval applications (PMAs): guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, December 16, 2019

Subject(s):

Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

19. Access and use of electronic health information by individuals with cancer: 2017-2018

Author(s):

Johnson, Christian, MPH, author
Krakow, Melinda, author
Patel, Vaishali, author

Publication:

Washington, DC : U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology, January 2020

Subject(s):

Electronic Health Records -- statistics & numerical data
Facilities and Services Utilization -- statistics & numerical data
Health Services Accessibility -- statistics & numerical data
Neoplasms
United States
United States. Department of Health and Human Services

20. Access to Medicare Part D plans: a comparison of metropolitan and nonmetropolitan areas

Author(s):

Nataliansyah, Mochamad, author
Salako, Abiodun, author
Ullrich, Fred, author
Mueller, Keith, author

Publication:

Iowa City, IA : Rural Policy Research Institute, May 2020

Subject(s):

Medicare Part D -- statistics & numerical data
Rural Population
Urban Population
United States

21. Access to preventive services without cost-sharing: evidence from the Affordable Care Act

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, January 11, 2022

Subject(s):

Cost Sharing
Health Services Accessibility
Preventive Health Services -- economics
Facilities and Services Utilization -- statistics & numerical data
United States
United States.

22. The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program: guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, September 25, 2020

Subject(s):

Accreditation
Equipment and Supplies
Materials Testing
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

23. Achieving behavioral health care integration in rural America

Publication:

Washington, DC : Bipartisan Policy Center, May 2023

Subject(s):

Behavioral Medicine
Community Mental Health Services
Health Promotion -- legislation & jurisprudence
Health Services Accessibility
Rural Health Services
Social Determinants of Health
United States

24. Acne vulgaris: establishing effectiveness of drugs intended for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Acne Vulgaris -- drug therapy
Drug Evaluation -- standards
Clinical Trials as Topic -- standards
Endpoint Determination
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

25. Action level for inorganic arsenic in apple juice: guidance for industry

Publication:

College Park, MD : Center for Food Safety and Applied Nutrition, June 2023

Subject(s):

Arsenic
Food Safety
Food Supply
Government Regulation
United States

26. Acute myeloid leukemia: developing drugs and biological products for treatment : guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, October 2022

Subject(s):

Biological Products
Drug Development -- legislation & jurisprudence
Government Regulation
Leukemia, Myeloid, Acute -- drug therapy
United States
United States. Food and Drug Administration

27. Adaptive designs for clinical trials of drugs and biologics

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2019

Subject(s):

Adaptive Clinical Trials as Topic -- standards
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

28. Address Presented to the National Coalition on Television Violence, Washington, DC [Reminiscence]

Publication:

Produced: 2003

Archival Collection:

The C. Everett Koop Papers (Profiles in Science)

29. Address at the Bloomberg School of Public Health convocation, Class of 2001

Publication:

Produced: 23 May 2001

Archival Collection:

The Joshua Lederberg Papers (Profiles in Science)

30. Address to the Mid-Year Meeting of the National Association of Children's Hospitals and Related Institutions, Inc. (NACHRI), Alexandria, Virginia [Reminiscence]

Publication:

Produced: 2003

Archival Collection:

The C. Everett Koop Papers (Profiles in Science)

31. Addressing social determinants of health: examples of successful evidence-based strategies and current federal efforts

Author(s):

Whitman, Amelia, author
De Lew, Nancy, author
Chappel, Andre, author
Aysola, Victoria, author
Zuckerman, Rachael, author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, April 1, 2022

Subject(s):

Delivery of Health Care, Integrated
Evidence-Based Practice
Federal Government
Social Determinants of Health
United States

32. Addressing teen pregnancy risks for youth living in out-of-home care: implementing POWER through choices 2010 : implementation report

Author(s):

Meckstroth, Alicia, author
Barry, Megan, (Of Child Trends, Incorporated) author
Keating, Betsy, author
Kisker, Ellen Eliason, 1957- author
Andrews, Kristine Marcia, author

Publication:

Princeton, NJ : Mathematica Policy Research, December 15, 2014

Subject(s):

Pregnancy in Adolescence -- prevention & control
Sexually Transmitted Diseases -- prevention & control
Adolescent Health
Health Plan Implementation
Health Surveys
United States

33. Addressing the direct care workforce shortage: a bipartisan call to action

Publication:

Washington, DC : Bipartisan Policy Center, December 2023

Subject(s):

Emigrants and Immigrants
Government Regulation
Health Policy
Health Workforce
Home Care Services
Home Health Aides
Home Health Nursing
Medicare
United States

34. Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2023

Subject(s):

Biological Products
Drug Industry
Government Regulation
Pharmaceutical Preparations
Randomized Controlled Trials as Topic
United States

35. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, October 2, 2017

Subject(s):

Clinical Laboratory Techniques
Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

36. The Admissibility of Scientific Evidence in Court

Publication:

Produced: 7 August 2000

Archival Collection:

The Joshua Lederberg Papers (Profiles in Science)

37. Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, September 2018

Subject(s):

Financing, Government
Substance-Related Disorders -- prevention & control
Adolescent
Young Adult
United States
United States. Department of Education
United States. Department of Health and Human Services
United States. Department of Justice

38. Advance care planning among Medicare fee-for-service beneficiaries and practitioners: final report

Author(s):

He, Fang, author
Gasdaska, Angela, author
Friedman, Hannah, author
Wedehas, Brendan, author
Kirk, Alexis, author
Broyles, Ila, author
Karon, Sarita L., author

Publication:

[Washington, D.C.] : United States Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, September 2020

Subject(s):

Advance Care Planning
Medicare
Fee-for-Service Plans
United States

39. Advanced prostate cancer: developing gonadotropin-releasing hormone analogues

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2022

Subject(s):

Drug Development -- legislation & jurisprudence
Gonadotropin-Releasing Hormone
Prostatic Neoplasms -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

40. Advancement of emerging technology applications for pharmaceutical innovation and modernization

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2017

Subject(s):

Biomedical Technology -- standards
Drug Industry -- standards
Inventions
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

41. Advancing comprehensive primary care in Medicaid

Publication:

Washington, DC : Bipartisan Policy Center, July 2020

Subject(s):

Medicaid -- legislation & jurisprudence
Medicaid -- organization & administration
Medicaid -- standards
Primary Health Care
Healthcare Disparities
Insurance, Health
United States

42. Advancing primary prevention in human services. Key considerations for administrators and practitioners

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Human Services Policy, June 2023

Subject(s):

Primary Prevention -- organization & administration
Social Welfare
Social Work
United States

43. Advancing primary prevention in human services. Key considerations for policy designers and funding partners

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Offices of Human Services Policy, June 2023

Subject(s):

Primary Prevention -- organization & administration
Health Policy
Social Welfare
Social Work
United States

44. Advancing primary prevention in human services. Opportunities for people with lived experience

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Human Services Policy, June 2023

Subject(s):

Community Participation
Primary Prevention -- organization & administration
Social Welfare
Social Work
United States

45. Advancing primary prevention in human services: convening findings

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Offices of Human Services Policy, March 2023

Subject(s):

Community Support
Ill-Housed Persons
Poverty
Primary Prevention
Social Support
Social Work -- organization & administration
United States

46. Adverse events in hospitals. A quarter of Medicare patients experienced harm in October 2018

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2022

Subject(s):

Government Regulation
Hospitals
Medicare
Patient Harm -- prevention & control
Patient Harm -- statistics & numerical data
Patient Safety
United States

47. Adverse events in long-term-care hospitals: national incidence among Medicare beneficiaries

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2018

Subject(s):

Hospitals -- statistics & numerical data
Incidence
Long-Term Care -- statistics & numerical data
Medical Errors -- statistics & numerical data
Medicare
United States
United States. Agency for Healthcare Research and Quality
Centers for Medicare & Medicaid Services (U.S.)

48. Adverse events toolkit. Clinical guidance for identifying harm

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023

Subject(s):

Evaluation Studies as Topic
Government Regulation
Medical Errors
Patient Harm
Risk Management
United States

49. Adverse events toolkit. Medical record review methodology

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023

Subject(s):

Evaluation Studies as Topic
Government Regulation
Medical Errors
Medical Records
Patient Harm
Risk Management
United States

50. The Affordable Care Act and African Americans

Author(s):

Robinson, Wilma, author
Finegold, Kenneth, 1957- author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, April 12, 2012

Subject(s):

Black or African American
Health Insurance Exchanges -- statistics & numerical data
Health Services Accessibility -- economics
Insurance Coverage -- statistics & numerical data
Medically Uninsured -- ethnology
United States
United States.

51. The Affordable Care Act and Asian Americans and Pacific Islanders

Author(s):

Chu, Rose C., author
Wong, Daniel, author
Robinson, Wilma, author
Finegold, Kenneth, 1957- author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, May 1, 2012

Subject(s):

Asian
Health Insurance Exchanges -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Medically Uninsured -- ethnology
Native Hawaiian or Pacific Islander
Quality Improvement
United States
United States.

52. The Affordable Care Act and Latinos

Author(s):

Henderson, Ashley, active 2012 author
Robinson, Wilma, author
Finegold, Kenneth, 1957- author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, April 10, 2012

Subject(s):

Health Insurance Exchanges -- statistics & numerical data
Hispanic or Latino
Insurance Coverage -- statistics & numerical data
Medically Uninsured -- ethnology
Quality Improvement
United States
United States.

53. The Affordable Care Act and adolescents

Author(s):

Pilkey, Diane Elizabeth, author

Publication:

[Washington, D.C.] : Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation, August 2013

Subject(s):

Health Insurance Exchanges -- statistics & numerical data
Adolescent
Adolescent Health Services
Health Services Accessibility -- economics
Insurance Coverage -- statistics & numerical data
United States
United States.

54. The Affordable Care Act and women

Author(s):

Cuellar, Alison Evans, author
Simmons, Adelle, author
Finegold, Kenneth, 1957- author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, March 20, 2012

Subject(s):

Health Insurance Exchanges -- statistics & numerical data
Women
Insurance Coverage -- statistics & numerical data
Quality Improvement
Women's Health Services
United States
United States.

55. Affordable Care Act has led to historic, widespread increase in health insurance coverage

Author(s):

Avery, Kelsey, author
Finegold, Kenneth, 1957- author
Whitman, Amelia, author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, September 29, 2016

Subject(s):

Health Insurance Exchanges -- statistics & numerical data
Health Care Costs
Insurance Coverage -- statistics & numerical data
United States
United States.

56. Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees

Publication:

Washington, D.C. : U.S. Government Accountability Office, September 2017

Subject(s):

Age Factors
Health Benefit Plans, Employee -- economics
Sex Factors
Taxes -- legislation & jurisprudence
United States
United States. Internal Revenue Service
United States.

57. The Affordable Care Act: advancing the health of women and children

Author(s):

Simmons, Adelle, author
Warren, Katherine E., author
McClain, Kellyann, author

Publication:

[Washington, D.C.] : Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation, January 9, 2015

Subject(s):

Health Insurance Exchanges -- statistics & numerical data
Child Health Services
Health Care Reform
Quality of Health Care
Women's Health Services
United States
United States.

58. The Affordable Care Act: promoting better health for women

Author(s):

Simmons, Adelle, author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, June 14, 2016

Subject(s):

Health Insurance Exchanges
Women's Health
Health Promotion -- economics
Quality Improvement -- economics
Program Evaluation
United States
United States.

59. The aging services network: accomplishments and challenges in serving a growing elderly population

Publication:

Washington, D.C. : George Washington University, [2008]

Subject(s):

Community Health Services -- legislation & jurisprudence
Health Services for the Aged -- legislation & jurisprudence
Health Services for the Aged -- trends
Health Services Needs and Demand -- trends
United States

60. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

Publication:

Washington, D.C. : U.S. Government Accountability Office, July 2017

Subject(s):

Air Ambulances -- economics
Fees and Charges
Insurance Coverage -- economics
United States
United States. Department of Transportation
Centers for Medicare & Medicaid Services (U.S.)

61. Air travel and communicable diseases: Federal leadership needed to advance research : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, July 2022

Subject(s):

Air Travel
Disease Transmission, Infectious -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Travel-Related Illness -- prevention & control
United States

62. Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, June 23, 2020

Subject(s):

Air Travel
Communicable Diseases -- transmission
Disaster Planning -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Travel-Related Illness
COVID-19 -- transmission
United States

63. Alaska State Medicaid Fraud Control Unit: 2016 onsite review

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017

Subject(s):

Fraud -- prevention & control
Medicaid
Alaska
United States
United States. Department of Health and Human Services

64. Allergic rhinitis: developing drug products for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2018

Subject(s):

Drug Evaluation
Rhinitis, Allergic -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

65. Alternative payment models and the slowdown in federal health care spending: testimony before the Committee on the Budget, United States Senate

Author(s):

Cohen, Michael, (Of Congressional Budget Office), author
White, Chapin, author

Publication:

[Washington, D.C.] : Congressional Budget Office, October 18, 2023

Subject(s):

Accountable Care Organizations
Federal Government
Health Expenditures -- trends
Reimbursement Mechanisms
United States

66. Alternative procedures for blood and blood components during the COVID-19 public health emergency

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, April 2020

Subject(s):

Blood Donors
Blood Transfusion
Plasma
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

67. Alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical: guidance for industry

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, June 2023

Subject(s):

Biological Products -- standards
Blood Platelets
Government Regulation
Platelet Transfusion
Refrigeration
United States

68. Alternative ways of financing graduate medical education: working paper

Author(s):

Wynn, Barbara O., author
Guarino, Cassandra M., author
Morse, Lindsey, author
Cho, Michelle, (Economist) author

Publication:

[Santa Monica, Calif.] : Rand Health, May 2006

Subject(s):

Education, Medical, Graduate -- economics
Public Policy
Medicare -- economics
United States

69. An American Indian/Alaska Native suicide prevention hotline: literature review and discussion with experts

Author(s):

Halpern, Peggy L., author

Publication:

[Washington, D.C.] : [Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services], [2009]

Subject(s):

Suicide Prevention
Crisis Intervention
Suicide -- ethnology
Indians, North American
Inuit
Hotlines
United States -- ethnology

70. [Amphioxus and ascidian]

Publication:

Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, 2009

Subject(s):

Urochordata
Books
Chordata

71. Amyotrophic lateral sclerosis: developing drugs for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2019

Subject(s):

Amyotrophic Lateral Sclerosis -- drug therapy
Clinical Trials as Topic -- standards
Drug Development -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

72. Analysis of 2017 premium changes and insurer participation in the Affordable Care Act's health insurance marketplaces

Author(s):

Cox, Cynthia, author
Claxton, Gary, author
Levitt, Larry, author
Long, Michelle, author
Gonzales, Selena, author
Sroczynski, Nolan, author

Publication:

Menlo Park, CA : Henry J. Kaiser Family Foundation, July 2016

Subject(s):

Health Insurance Exchanges -- economics
Health Insurance Exchanges -- statistics & numerical data
Insurance, Health -- economics
Insurance, Health -- statistics & numerical data
United States
United States.

73. An analysis of private-sector prices for hospital admissions

Author(s):

Maeda, Jared Lane, author
Nelson, Lyle, author

Publication:

[Washington, D.C.] : Congressional Budget Office, April 2017

Subject(s):

Hospital Costs -- statistics & numerical data
Insurance, Health, Reimbursement
Medicare -- economics
Medicare Part C -- economics
Private Sector
United States

74. An analysis of private-sector prices for physicians' services

Author(s):

Pelech, Daria, author

Publication:

Washington, D.C. : Congressional Budget Office, January 2018

Subject(s):

Fee-for-Service Plans -- economics
Fees and Charges -- statistics & numerical data
Medicare -- economics
Physicians
United States

75. Analysis of supply, distribution, demand, and access issues associated with immune globulin intravenous (IGIV): final report

Author(s):

Eastern Research Group, Inc., author.

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2007

Subject(s):

Immunoglobulins, Intravenous -- economics
Immunoglobulins, Intravenous -- therapeutic use
Medicare
United States

76. Anesthesia services: differences between private and Medicare payments likely due to providers' strong negotiating position : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, October 2020

Subject(s):

Anesthesia -- economics
Medicare -- economics
United States
Centers for Medicare & Medicaid Services (U.S.)

77. Animal kingdom arranged in conformity with its organization

Publication:

Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, 2009

Subject(s):

Books

78. Animal use in research: NIH should strengthen oversight of projects it funds at foreign facilities : report to congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, March 2023

Subject(s):

Animal Experimentation -- legislation & jurisprudence
Animal Experimentation -- standards
Government Regulation
International Cooperation -- legislation & jurisprudence
Legislation, Medical
Research -- economics
United States

79. Animals, anatomy, and natural history in Louis XIV's Paris

Publication:

[Bethesda, Md.] : National Library of Medicine, [2007]

Subject(s):

Natural History -- history
Animals, Zoo -- anatomy & histology
Dissection -- history
History, 17th Century
Philosophy -- history
Paris
Du Verney, M., 1648-1730.
Perrault, Claude, 1613-1688.

80. [The manner in which the blood spatters from the syringe]

Publication:

Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, 2010

Subject(s):

Blood
Diffusion
Syringes

81. Annual status report information and other submissions for postmarketing requirements and commitments: using forms FDA 3988 and FDA 3989 : guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2023

Subject(s):

Forms as Topic
Government Regulation
Product Surveillance, Postmarketing
United States
United States.
United States.

82. Answering the call: 988 : a new vision for crisis response

Publication:

Washington, D.C. : Bipartisan Policy Center, June 2022

Subject(s):

Crisis Intervention -- organization & administration
Hotlines
United States

83. Answers to questions for the record following a hearing conducted by the House Committee on the Budget: key design components and considerations for establishing a single-payer health care system

Publication:

[Washington, DC] : Congressional Budget Office, December 20, 2019

Subject(s):

Single-Payer System -- organization & administration
Budgets
United States

84. Anthrax: developing drugs for prophylaxis of inhalational anthrax

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Anthrax -- drug therapy
Anthrax -- prevention & control
Antibiotic Prophylaxis
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Inhalation Exposure
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

85. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2017

Subject(s):

Anti-Bacterial Agents -- therapeutic use
Bacterial Infections -- drug therapy
Drug Approval
Drug Resistance, Bacterial
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

86. Antibiotic resistance: Federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, April 28, 2023

Subject(s):

Drug Resistance, Microbial
Government Regulation
Legislation, Medical
United States
United States. Department of Health and Human Services

87. Antibiotic resistance: additional federal actions needed to better determine magnitude and reduce impact

Publication:

Washington, DC : United States Government Accountability Office, March 2020

Subject(s):

Bacterial Infections -- therapy
Drug Resistance, Bacterial
Diagnostic Techniques and Procedures
Epidemiological Monitoring
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

88. Antibiotic resistance: more information needed to oversee use of medically important drugs in food animals : report to Congressional requesters

Publication:

Washington, D.C. : U.S. Government Accountability Office, March 2017

Subject(s):

Anti-Bacterial Agents -- adverse effects
Anti-Bacterial Agents -- therapeutic use
Bacterial Infections -- drug therapy
Drug Resistance, Bacterial
Drug Resistance, Microbial
Food -- adverse effects
Food Inspection
Food Safety
Foodborne Diseases -- microbiology
Veterinary Drugs -- adverse effects
Veterinary Drugs -- therapeutic use
Canada
Denmark
Netherlands
United States
United States. Department of Agriculture
United States. Department of Health and Human Services

89. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters

Publication:

Washington, D.C. : U.S. Government Accountability Office, January 2017

Subject(s):

Anti-Bacterial Agents -- therapeutic use
Drug Approval
Drug Industry
Drugs, Investigational
Investigational New Drug Application
United States
United States. Food and Drug Administration

90. Antimicrobial susceptibility test (AST) system devices: updating breakpoints in device labeling : guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, September 29, 2023

Subject(s):

Government Regulation
Medical Device Legislation
Microbial Sensitivity Tests -- standards
Product Labeling
United States

91. Antipsychotic medication prescribing in long-term care facilities increased in the early months of the COVID-19 pandemic

Author(s):

Oliveira, Iara, author
Bianco, Martin, author
Ali, Mir M., (Health economist) author

Publication:

Washington, D.C. : Assistant Secretary for Planning and Evaluation, March 8, 2022

Subject(s):

COVID-19
Antipsychotic Agents -- therapeutic use
Inappropriate Prescribing -- trends
Long-Term Care
Nursing Homes
United States

92. Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, September 2023

Subject(s):

Antiviral Agents -- economics
Antiviral Agents -- supply & distribution
Government Regulation
Legislation, Medical
Pandemic Preparedness
Technology Assessment, Biomedical
United States

93. Anxiety and post-traumatic stress

Publication:

[Bethesda, Md. : Medical Arts and Photography Branch, National Institutes of Health, 2002]

Subject(s):

Anxiety Disorders -- prevention & control
Fear -- psychology
Stress Disorders, Post-Traumatic -- prevention & control

94. Apoptosis in the male reproductive tract

Publication:

[Bethesda, Md. : Medical Arts and Photography Branch, National Institutes of Health, 2002]

Subject(s):

Apoptosis
Genitalia, Male

95. The apotheosis of the dissected plate: spectacles of layering & transparency in the 19th and 20th century anatomy : traversing the text/body binary for profit & pleasure

Author(s):

Sappol, Michael, author

Publication:

[Bethesda, Md.] : [National Institutes of Health, History of Medicine Division], 2015

Subject(s):

Anatomy, Cross-Sectional -- history
Dissection -- history
History, 19th Century
History, 20th Century
Medical Illustration -- history

96. Appeal options available to mammography facilities concerning adverse accreditation decisions, suspension/revocation of certificates, or patient and physician notification orders: guidance for mammography facilities and Food and Drug Administration staff

Publication:

[Silver Spring, MD] : Center for Devices and Radiological Health, March 2, 2022

Subject(s):

Accreditation
Facility Regulation and Control
Mammography
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

97. An appeal to humanity: in an account of the life and cruel actions of Elizabeth Brownrigg

Publication:

Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, 2010

Subject(s):

Pamphlets

98. Appendix I (B) to the ICH E2B(R3) ICSRs implementation guide: backwards and forwards compatibility

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 2022

Subject(s):

Clinical Coding
Databases, Pharmaceutical
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

99. Application of human factors engineering principles for combination products: questions and answers : guidance for industry and FDA staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, September 2023

Subject(s):

Bioengineering
Device Approval
Drug Development
Drug Industry
Ergonomics
Government Regulation
United States

100. Approaches to changing military health care

Publication:

Washington, D.C. : Congressional Budget Office, October 2017

Subject(s):

Health Care Reform -- organization & administration
Military Medicine -- organization & administration
United States
United States. Department of Defense